Bone marrow hypoplasia responsive to testosterone therapy in a patient with panhypopituitarism: Need for adherence to androgen replacement

Endocrine Practice

Volumn 14, Issue 2, 2008, Pages 229-232

  Badawi, Manal A ^a   Salih, Farah ^a   Al Humaidi, Abdel Aziz ^a   El Khalifa, Mohamed Y ^a   Elhadd, Tarik A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TESTOSTERONE DECANOATE; TESTOSTERONE DERIVATIVE; UNCLASSIFIED DRUG; ANDROGEN; TESTOSTERONE;

ADULT; ANDROGEN THERAPY; ARTICLE; BONE MARROW BIOPSY; BONE MARROW HYPOPLASIA; CASE REPORT; DRUG WITHDRAWAL; GLIOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOPITUITARISM; LEUKOCYTE COUNT; MAINTENANCE THERAPY; MALE; MEGAKARYOCYTE; PANCYTOPENIA; PATIENT COMPLIANCE; RECURRENT DISEASE; SAUDI ARABIA; SEPSIS; THROMBOCYTE COUNT; ADOLESCENT; BONE MARROW; BONE MARROW DISEASE; DRUG EFFECT; HORMONE SUBSTITUTION; PATHOLOGY;

ADOLESCENT; ANDROGENS; BONE MARROW; BONE MARROW DISEASES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM; MALE; PANCYTOPENIA; TESTOSTERONE;

EID: 45849150409     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.2.229     Document Type: Article

References (18)

1. Shahidi NT. Androgens and erythropoiesis. N Engl J Med. 1973;289:72-80.
2. Neff MS, Goldberg J, Slifkin RF, et al. A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med. 1981;304:871-875.
3. Singer JW, Adamson JW. Steroids and haematopoiesis. III. The response of granulocytic and erythroid colony-forming cells to steroids of different classes. Blood. 1976;48:855-864.
4. Gallicchio VS, Chen MG, Watts TD. Regeneration of murine megakaryocytopoiesis and the hematopoietic inductive microenvironment after sublethal whole body irradiation by treatment with an anabolic steroid. Acta Haematol. 1985;73:80-85.
5. Young NS, Alter BP. Clinical features of Fanconi's anemia. In: Young NS, Alter BP, eds. Aplastic Anemia Acquired and Inherited. Philadelphia, PA: WB Saunders, 1994: 275-309.
6. Ferrari E, Ascari E, Bossolo PA, Barosi G. Sheehan's syndrome with complete bone marrow aplasia: long-term results of substitution therapy with hormones. Br J Haematol. 1976;33:575-582.
7. Kim DY, Kim JH, Park YJ, et al. Case of complete recovery of pancytopenia after treatment of hypopituitarism. Ann Hematol. 2004;83:309-312.
8. Ozdogan M, Yazicioglu G, Karadogan I, Cevikol C, Karayalcin U, Undar L. Sheehan's syndrome associated with pancytopenia due to marrow aplasia: full recovery with hormone replacement therapy. Int J Clin Pract. 2004;58:533-535.
9. Ucci G, Barosi G, Riccardi A, et al. Anemia in hypopituitarism: evidence of hormone-dependent qualitative abnormalities of erythropoiesis. Haematologica. 1986;71:395-400.
10. Rudzki Z, Matynia A, Przybylik-Mazurek E, et al. Hypopituitarism and hematological abnormalities mimicking myelodysplastic syndrome: report of four cases [article in Polish]. Pol Arch Med Wewn. 2003;110:1003-1011.
11. Strum SB, Tisman G. Anemia of androgen deprivation (AAD) in patients receiving combination hormone blockade: response to erythropoietin. Proc Am Soc Clin Oncol. 1994;13:238.
12. Sullivan PS, Jackson CW, McDonald TP. Castration decreases thrombocytopoiesis and testosterone restores platelet production in castrated BALB/c mice: evidence that testosterone acts on a bipotential hematopoietic precursor cell. J Lab Clin Med. 1995;125:326-333.
13. Piedras J, Hernández G, López-Karpovitch X. Effect of androgen therapy and anemia on serum erythropoietin levels in patients with aplastic anemia and myelodysplastic syndromes. Am J Hematol. 1998;57:113-118.
14. Tsiara SN, Chaidos A, Gouva M, et al. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone. J Exp Clin Cancer Res. 2004;23:47-52.
15. Hast R, Engstedt L, Jameson S, et al. Oxymetholone treatment in myelofibrosis. Blut. 1978;37:19-26.
16. Wattel E, Cambier N, Caulier MT, Sautière D, Bauters F, Fenaux P. Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases. Br J Haematol. 1994;87:205-208.
17. Maloisel F, Andrès E, Zimmer J, et al. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results. Am J Med. 2004;116:590-594.
18. Tristano AG. Acquired amegakaryocytic thrombocytopenic purpura: review of a not very well-defined disorder. Eur J Int Med. 2005;16:477-481.